WF14861, a new cathepsins B and L inhibitor produced by Colletotrichum sp. II. Biological properties

Journal of Antibiotics

Volumn 52, Issue 6, 1999, Pages 542-547

  Otsuka, Takanao ^a   Muramatsu, Yuko ^a   Niikura, Kazuaki ^a   Okamoto, Masanori ^a   Hino, Motohiro ^a   Hashimoto, Seijji ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 [N [1 [N (4 AMINOBUTYL) N (3 AMINOPROPYL)CARBAMOYL] 2 (4 HYDROXYPHENYL)ETHYL]CARBAMOYL] 2 OXIRANECARBOXYLIC ACID; CALCIUM; CATHEPSIN B; CATHEPSIN L; CHYMOSTATIN; CYSTEINE PROTEINASE; ENZYME INHIBITOR; LEUPEPTIN; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PROTEINASE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DESTRUCTION; CALCIUM BLOOD LEVEL; CALCIUM DEFICIENCY; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE INJURY;

COLLETOTRICHUM;

EID: 0032865641     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.542     Document Type: Article

References (10)

1. MACIEWICZ, R. A. & S. F. WOTTON: Degradation of cartilage matrix components by the cysteine proteinases, cathepsins B and L. Biomed. Biochim. Acta 50: 561-564, 1991
2. FLIPO, R.-M.; G. HUET, F. MAURY, F. ZERIMECH, C. FONTAINE, B. DUQUESNOY, P. DEGAND & B. DELCAMBRE: Cysteine-proteolytic activities (cathepsins B, L and calpains) in rheumatoid synovium. Arthritis & Rheum. 36: S252, 1993
3. OTSUKA, T.; Y. MURAMATSU, T. HIGAKI, T. NAKANISHI, S. TAKASE, H. HATANAKA, M. OKAMOTO, M. HINO & S. HASHIMOTO: WF14861, a new cathepsins B and L inhibitor produced by Colletoirichum sp. I. Taxonomy, production, purification and structure elucidation. J. Antibiotics 52: 536-541, 1999
4. YAMAMOTO, N.; F. SAKAI, H. YAMAZAKI, Y. KAWAI, K. NAKAHARA & M. OKUHARA: Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats. J. Rheumatol. 23: 1778-1783, 1996
5. DELAISSÁ, J.-M.; Y. EECKHOUT & G. VAES: In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem. Biophys. Res. Commun. 125: 441-447, 1984
6. GOUR-SALIN, B.; P. LACHANCE, C. PLOUFFE, A. C. STORER & R. MÉNARD: Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B. J. Med. Chem. 36: 720-725, 1993
7. TOWATARI, T.; T. NIKAWA, M. MURATA, C. YOKOO, M. TAMAI, K. HANADA & N. KATUNUMA: Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo. FEBS 280: 311-315, 1991
8. AHMED, N. K.; L. A. MARTIN, L. M. WATTS, J. PALMER, L. THORNBURG, J. PRIOR & R. E. ESSER: Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Biochem. Pharmacol. 44: 1201-1207, 1992
9. ESSER, R. E.; L. M. WATTS, R. A. ANGELO, L. P. THORNBURG, J. J. PRIOR & J. T. PALMER: The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant arthritis. J. Rheumatol. 20: 1176-1183, 1993
10. AIBE, K.; H. YAZAWA, K. ABE, K. TERAMURA, M. KUMEGAWA, H. KAWASHIMA & K. HONDA: Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol. Pharm. Bull. 19: 1026-1031, 1996